Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05586672 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HR-EEG Contribution in Prognostic Evaluation of Language Development in Children With ASD

Study acronym: EE-TSA-LANG
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this prospective observational multicentric cohort study is to evaluate the clinical prognostic value of the speech tracking score of language development in children with ASD aged from 3 years to 4 years and half at inclusion. Participants will followed during 4 years with an annual visit. During these visits, each participant will be clinically evaluated (scales and tests) and performed an EEG-HR recording. Two groups will be formed, one with children diagnosed with ASD with language delay, and a control group composed of non-ASD children without language delay, matched on age and gender with the ASD group.
Trial Details
NCT Number NCT05586672
Lead Sponsor Etablissement Public de Santé Barthélemy Durand
Conditions
(from sponsor)		 Autism Spectrum Disorder, Language Development, Neurocognitive Disorders, Child Language
Related terms Autism Spectrum Disorder, Language, Neurocognitive Disorders
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov